FemTech Startups

FemTech funding concentrates in three categories and seven investors who matter most.

Femtech founders win funding by naming the clinical gap and addressing investor hesitations upfront.

Femtech founders should choose programs by stage, vertical fit, and actual investor access.

Mastering "intended use" and the three FDA pathways can cut years off your regulatory timeline.

Investors now demand clinical data and regulatory clarity even at the seed stage.

Britain's femtech market has tripled in a decade, making it second only to the US globally.

When ad platforms censor anatomy, FemTech brands build owned channels instead.

The two FemTech models split on who pays, reshaping everything from sales to survival.

The sector raised $724 million last year; here's which companies have the budget to actually hire.

A funding boom has created clear winners, but the capital era that built them is ending.